ArticleBlood cancer discovery2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.
Carlos Fernández de Larrea et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
172 papers cite itlatest 60 shown
this paperpooled ittrialcites it